212 related articles for article (PubMed ID: 21559372)
1. IL-6 stabilizes Twist and enhances tumor cell motility in head and neck cancer cells through activation of casein kinase 2.
Su YW; Xie TX; Sano D; Myers JN
PLoS One; 2011 Apr; 6(4):e19412. PubMed ID: 21559372
[TBL] [Abstract][Full Text] [Related]
2. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis.
Na YR; Lee JS; Lee SJ; Seok SH
Melanoma Res; 2013 Dec; 23(6):434-43. PubMed ID: 24051540
[TBL] [Abstract][Full Text] [Related]
4. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
[TBL] [Abstract][Full Text] [Related]
5. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
[TBL] [Abstract][Full Text] [Related]
6. Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck.
Kojc N; Zidar N; Gale N; Poljak M; Fujs Komlos K; Cardesa A; Höfler H; Becker KF
Virchows Arch; 2009 May; 454(5):549-55. PubMed ID: 19381684
[TBL] [Abstract][Full Text] [Related]
7. Twist-related protein 1 enhances oral tongue squamous cell carcinoma cell invasion through β-catenin signaling.
Zheng L; Li N; Guo F; Jian XC; Jiang CH; Yin P; Min AJ; Huang L
Mol Med Rep; 2015 Mar; 11(3):2255-61. PubMed ID: 25378227
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase casein kinase 2 mediates inhibitor-kappaB kinase and aberrant nuclear factor-kappaB activation by serum factor(s) in head and neck squamous carcinoma cells.
Yu M; Yeh J; Van Waes C
Cancer Res; 2006 Jul; 66(13):6722-31. PubMed ID: 16818647
[TBL] [Abstract][Full Text] [Related]
9. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
Bendinelli P; Maroni P; Matteucci E; Desiderio MA
Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
[TBL] [Abstract][Full Text] [Related]
10. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
11. PKB/AKT phosphorylation of the transcription factor Twist-1 at Ser42 inhibits p53 activity in response to DNA damage.
Vichalkovski A; Gresko E; Hess D; Restuccia DF; Hemmings BA
Oncogene; 2010 Jun; 29(24):3554-65. PubMed ID: 20400976
[TBL] [Abstract][Full Text] [Related]
12. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
13. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma.
Zang C; Liu X; Li B; He Y; Jing S; He Y; Wu W; Zhang B; Ma S; Dai W; Li S; Peng Z
Oncotarget; 2017 Feb; 8(7):11228-11238. PubMed ID: 28061440
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
15. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
16. Silmitasertib, a casein kinase 2 inhibitor, induces massive lipid droplet accumulation and nonapoptotic cell death in head and neck cancer cells.
Su YW; Huang WY; Lin HC; Liao PN; Lin CY; Lin XY; Huang SH; Chen YT; Wu PS
J Oral Pathol Med; 2023 Mar; 52(3):245-254. PubMed ID: 36273268
[TBL] [Abstract][Full Text] [Related]
17. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
[TBL] [Abstract][Full Text] [Related]
18. Expression of a dominant-negative mutant inhibitor-kappaBalpha of nuclear factor-kappaB in human head and neck squamous cell carcinoma inhibits survival, proinflammatory cytokine expression, and tumor growth in vivo.
Duffey DC; Chen Z; Dong G; Ondrey FG; Wolf JS; Brown K; Siebenlist U; Van Waes C
Cancer Res; 1999 Jul; 59(14):3468-74. PubMed ID: 10416612
[TBL] [Abstract][Full Text] [Related]
19. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
[TBL] [Abstract][Full Text] [Related]
20. Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma.
Banerjee R; Henson BS; Russo N; Tsodikov A; D'Silva NJ
Cell Signal; 2011 Jul; 23(7):1110-8. PubMed ID: 21345369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]